Supernus’ depression drug improved symptoms in two hours in Phase IIa study

Supernus’ depression drug improved symptoms in two hours in Phase IIa study

Submitted by admin on October 20, 2024 - 10:24pm
Source: 
Clinical Trials Arena
News Tags: 
Supernus Pharmaceuticals
SPN-820
major depressive disorder
clinical trials
Headline: 
Supernus’ depression drug improved symptoms in two hours in Phase IIa study
snippet: 

Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial for adults with major depressive disorder (MDD).

Do Not Allow Advertisers to Use My Personal information